Landis P - Search Results

1

Using nuclear morphometry to predict the need for treatment among men with low grade, low stage prostate cancer enrolled in a program of expectant management with curative intent.

Makarov DV, Marlow C, Epstein JI, Miller MC, Landis P, Partin AW, Carter HB, Veltri RW. Makarov DV, et al. Among authors: landis p. Prostate. 2008 Feb 1;68(2):183-9. doi: 10.1002/pros.20679. Prostate. 2008. PMID: 18085616 Free PMC article.

2

Change in prostate cancer grade over time in men followed expectantly for stage T1c disease.

Sheridan TB, Carter HB, Wang W, Landis PB, Epstein JI. Sheridan TB, et al. J Urol. 2008 Mar;179(3):901-4; discussion 904-5. doi: 10.1016/j.juro.2007.10.062. Epub 2008 Jan 22. J Urol. 2008. PMID: 18207195 Free PMC article.

3

Expectant management of nonpalpable prostate cancer with curative intent: preliminary results.

Carter HB, Walsh PC, Landis P, Epstein JI. Carter HB, et al. Among authors: landis p. J Urol. 2002 Mar;167(3):1231-4. J Urol. 2002. PMID: 11832703

4

Can prostate specific antigen derivatives and pathological parameters predict significant change in expectant management criteria for prostate cancer?

Khan MA, Carter HB, Epstein JI, Miller MC, Landis P, Walsh PW, Partin AW, Veltri RW. Khan MA, et al. Among authors: landis p. J Urol. 2003 Dec;170(6 Pt 1):2274-8. doi: 10.1097/01.ju.0000097124.21878.6b. J Urol. 2003. PMID: 14634395

5

Delayed versus immediate surgical intervention and prostate cancer outcome.

Warlick C, Trock BJ, Landis P, Epstein JI, Carter HB. Warlick C, et al. Among authors: landis p. J Natl Cancer Inst. 2006 Mar 1;98(5):355-7. doi: 10.1093/jnci/djj072. J Natl Cancer Inst. 2006. PMID: 16507832 Free PMC article.

6

Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience.

Carter HB, Kettermann A, Warlick C, Metter EJ, Landis P, Walsh PC, Epstein JI. Carter HB, et al. Among authors: landis p. J Urol. 2007 Dec;178(6):2359-64; discussion 2364-5. doi: 10.1016/j.juro.2007.08.039. Epub 2007 Oct 22. J Urol. 2007. PMID: 17936806 Free PMC article.

7

DNA content in the diagnostic biopsy for benign-adjacent and cancer-tissue areas predicts the need for treatment in men with T1c prostate cancer undergoing surveillance in an expectant management programme.

Isharwal S, Makarov DV, Carter HB, Epstein JI, Partin AW, Landis P, Marlow C, Veltri RW. Isharwal S, et al. Among authors: landis p. BJU Int. 2010 Feb;105(3):329-33. doi: 10.1111/j.1464-410X.2009.08791.x. Epub 2009 Aug 12. BJU Int. 2010. PMID: 19678815

8

Accuracy of PCA3 measurement in predicting short-term biopsy progression in an active surveillance program.

Tosoian JJ, Loeb S, Kettermann A, Landis P, Elliot DJ, Epstein JI, Partin AW, Carter HB, Sokoll LJ. Tosoian JJ, et al. Among authors: landis p. J Urol. 2010 Feb;183(2):534-8. doi: 10.1016/j.juro.2009.10.003. Epub 2009 Dec 14. J Urol. 2010. PMID: 20006883

9

Risk stratification of men choosing surveillance for low risk prostate cancer.

Tseng KS, Landis P, Epstein JI, Trock BJ, Carter HB. Tseng KS, et al. Among authors: landis p. J Urol. 2010 May;183(5):1779-85. doi: 10.1016/j.juro.2010.01.001. Epub 2010 Mar 20. J Urol. 2010. PMID: 20304433 Free PMC article.

10

Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program.

Ross AE, Loeb S, Landis P, Partin AW, Epstein JI, Kettermann A, Feng Z, Carter HB, Walsh PC. Ross AE, et al. Among authors: landis p. J Clin Oncol. 2010 Jun 10;28(17):2810-6. doi: 10.1200/JCO.2009.25.7311. Epub 2010 May 3. J Clin Oncol. 2010. PMID: 20439642

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

102 results

Search Page